IMW: International Myeloma Workshop

Conference Coverage

Combo demonstrates potential in MM

ROME—Early results of a pilot study indicate that a 3-agent combination regimen can produce responses in patients with relapsed or refractory...

Conference Coverage

mAb produces ‘encouraging’ results in MM

multiple myeloma ROME—Combination therapy incorporating a novel monoclonal antibody (mAb) can provide “encouraging, long-lasting tumor control”...